Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 10, 2019
MellingMedical announced a vital distribution relationship with Katena Products.
read more
Wednesday, February 03, 2021
Meitheal Pharmaceuticals is voluntarily recalling one (1) lot of Cisatracurium Besylate Injection, USP 10mg per 5mL to the user level.
read more
Friday, September 13, 2019
Meitheal announced the launch of the Company’s eight presentations of heparin sodium injection, USP in the US.
read more
Meissa Vaccines a clinical-stage biotechnology company developing vaccines to prevent viral respiratory infections, has entered into a manufacturing agreement with Exothera S.A., a Univercells company and full-service Contract Research Development ...
read more
Meissa Vaccines has been awarded a Fast Track SBIR grant by the NIH to fund activities needed to file an IND application with the FDA for Meissa's vaccine to prevent RSV disease in infants.
read more
Meissa Vaccines announced it has been awarded a Phase 1 SBIR grant by the National Institutes of Health entitled "Development of polyvalent inactivated rhinovirus vaccine."
read more
Monday, November 08, 2021
Meiji Seika Pharma Co., Ltd. has been decided to construct a new manufacturing facility at Adcock Ingram Ltd. in Bengaluru, India.
read more
Wednesday, September 06, 2017
MEI Pharma has entered into a license agreement with Presage Biosciences for voruciclib, a clinical-stage, oral and selective CDK inhibitor.
read more
Friday, September 15, 2017
MedSource is growing its service-offering to include the early stages of clinical development and pipeline planning through Investigational New Drug submissions.
read more
Wednesday, September 08, 2021
Medrio, Inc., and PHASTAR announced that they have partnered to leverage metadata surrounding electronic patient-reported outcomes (ePRO) for advanced data visualization, providing insight into patient compliance and burden.
read more
MedReleaf and BioPharma Services have entered into an exclusive agreement to conduct clinical research for cannabis and cannabis derived products.
read more
Friday, December 22, 2017
MedPharm has received positive outcomes from recent cGMP and GLP inspections in 2017.
read more
Wednesday, March 28, 2018
MedPharm announced a multi-million dollar investment by Ampersand Capital Partners.
read more
MedPharm Ltd, a world-leading contract developer of topical and transdermal pharmaceutical products, is opening a new location in Raleigh-Durham, North Carolina that will expand its CDMO services in topical and transdermal delivery.
read more
Thursday, December 05, 2019
MedPharm has moved into its newly expanded facility in Durham, North Carolina.
read more